Cargando…
Neovascular Age-Related Macular Degeneration in the Very Old (≥90 Years): Epidemiology, Adherence to Treatment, and Comparison of Efficacy
PURPOSE: To investigate neovascular age-related macular degeneration (AMD) in patients aged ≥90 years from several perspectives for a comprehensive overview: prevalence, presenting characteristics, treatment adherence, reasons for discontinuation, and efficacy of antivascular endothelial growth fact...
Autores principales: | Subhi, Yousif, Sørensen, Torben Lykke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474234/ https://www.ncbi.nlm.nih.gov/pubmed/28660080 http://dx.doi.org/10.1155/2017/7194927 |
Ejemplares similares
-
Altered activation state of circulating neutrophils in patients with neovascular age-related macular degeneration
por: Krogh Nielsen, Marie, et al.
Publicado: (2017) -
In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels
por: Subhi, Yousif, et al.
Publicado: (2013) -
Treatment failure in neovascular age-related macular degeneration is associated with a complex chemokine receptor profile
por: Bjerregaard, Thomas, et al.
Publicado: (2019) -
T-cell differentiation and CD56+ levels in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration
por: Subhi, Yousif, et al.
Publicado: (2017) -
Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration
por: Hector, Sven Magnus, et al.
Publicado: (2017)